Correspondence 0001140361-22-041917 from HCM Acquisition Corp (CIK 0001845368)
HCM Acquisition Corp (CIK 0001845368)
Date: Nov. 16, 2022 · CIK: 0001845368 · Accession: 0001140361-22-041917
AI Filing Summary & Sentiment
File numbers found in text: 001-41241
Show Raw Text
CORRESP
1
filename1.htm
King & Spalding LLP
1180 Peachtree Street N.E.
Atlanta, GA 30309-3521
www.kslaw.com
Kevin E. Manz
kmanz@kslaw.com
T 212.556.2133
F 212.556.2222
November 16, 2022
Securities and Exchange Commission
Division of Corporation Finance
Office of Real Estate & Construction
100 F Street, NE
Washington, DC 20549
Attn:
Ruairi Regan
Jeffrey Gabor
Re:
HCM Acquisition Corp
Preliminary Proxy Statement on Schedule 14A
Filed November 9, 2022
File No. 001-41241
Ladies and Gentlemen:
This letter responds to the comment letter (the “Comment Letter”) of the staff (the “Staff”) of the Division of Corporation Finance of the United States Securities and Exchange Commission (the “Commission”),
dated November 15, 2022, to Mr. James Bond, President and Chief Financial Officer of HCM Acquisition Corp (“HCM” or the “Company”) regarding the Preliminary Proxy Statement on Schedule 14A filed on November 9, 2022 (the “Preliminary
Proxy”).
This letter sets forth each comment of the Staff in the Comment Letter and, following the comment, sets forth the Company’s response.
Preliminary Proxy Statement on Schedule 14A
General
1.
With a view toward disclosure, please tell us whether your sponsor is, is controlled by, or has substantial ties with a non-U.S. person. If so, also include risk factor disclosure that addresses how this fact
could impact your ability to complete your initial business combination. For instance, discuss the risk to investors that you may not be able to complete an initial business combination with a U.S. target company should the transaction be
subject to review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Disclose that as a result, the pool of potential targets with which you could complete an
initial business combination may be limited. Further, disclose that the time necessary for government review of the transaction or a decision to prohibit the transaction could prevent you from completing an initial business combination and
require you to liquidate. Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and the warrants, which would expire
worthless.
November 16, 2022
Page Two
The Company respectfully acknowledges the Staff’s comment and submits that HCM Investor Holdings, LLC (the “HCM Sponsor”) is a Delaware limited liability company with a principal place of business in Connecticut.
Further, the managing member of the HCM Sponsor is Shawn Matthews, a U.S. person and resident of Connecticut. Additionally, to the best of the Company’s knowledge, all directors and officers of HCM are U.S. persons. As such the Company advises the
Staff that the HCM Sponsor is not, is not controlled by, and does not have substantial ties with a non-U.S. person.
November 16, 2022
Page Three
The Company and its management acknowledge they are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the Staff.
Please do not hesitate to contact Kevin E. Manz, Esq. at (212) 556-2133 if you have any questions regarding this letter.
Very truly yours,
/s/ King & Spalding LLP
King & Spalding LLP
Kevin E. Manz
Partner